Difference between revisions of "Part:BBa K4632002:Experience"

Line 4: Line 4:
 
how you used this part and how it worked out.
 
how you used this part and how it worked out.
  
===Construction and Characterization===
 
  
<p><strong> 1. Verifying the Expression and Secretion Proficiency of Cry3A-like Toxin</strong></p>
 
We conducted PCR amplification on the plasmid (procured from GUANGZHOU IGE BIOTECHNOLOGY LTD) to obtain the OmpA - Cry3A-like toxin segment. Subsequently, we utilized the Gibson Assembly method with the ABclonal 2× MultiF Seamless Assembly Mix kit to clone this segment into the pET30(a) plasmid. This resulted in the creation of the plasmid pET30a-OmpA-Cry3A-like toxin, as depicted in plasmid map Figure 1. Finally, we performed a transformation of this plasmid into <i>E. coli</i> BL21(DE3) to assess the secretion expression of the toxin protein.
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-7.png"
 
width="700"
 
title="Construction of pET30a-OmpA-Cry3A-like toxin"
 
 
<p> <figcaption><strong> Figure 1: </strong>Construction of pET30a-OmpA-Cry3A-like toxin </figcaption></p>
 
 
</figure>
 
 
<br>
 
<br>
 
 
The pET-30(a)-OmpA-Cry3A-like toxin (E.coli BL21(DE3)) was cultured overnight in LB medium. The following day, the culture was subjected to transformation, and IPTG induction was carried out for 3 hours. Subsequently, the culture was centrifuged at 6,000 rpm for 10 minutes to separate the cell pellet and the supernatant. Afterward, both fractions were subjected to SDS-PAGE analysis (as shown in Figure 2)
 
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-10.png"
 
width="700"
 
title="SDS-PAGE analysis of Cry3A-like toxin expression"
 
 
<p> <figcaption><strong> Figure 2: </strong>SDS-PAGE analysis of Cry3A-like toxin expression lane1:Concentrated protein supernatant of pET-30a(+IPTG); lane2:Concentrated protein supernatant of pET-30a-OmpA-Cry3A-like toxin(+IPTG); lane3:Concentrated protein supernatant of pET-30a-OmpA-Cry3A-like toxin(-IPTG) </figcaption></p>
 
 
</figure>
 
 
<br>
 
<br>
 
 
<p> The supernatant from the induced culture displayed a distinct 66.6 kDa band corresponding to Cry3A-like toxin, which was absent in the supernatant of the non-induced culture and the wild-type control. This observation confirms the successful secretion expression of Cry3A-like toxin.</p>
 
<p> Subsequently, we utilized the enzyme digestion ligation/ΩPCR method to add a 6×His tag to pET30a-OmpA-Cry3A-like toxin. This modification was carried out to facilitate Western blot experiments, further confirming the secretion expression of Cry3A-like toxin (as depicted in plasmid map Figure 3).</p>
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-1.png"
 
width="700"
 
title="Construction of pET30a-OmpA-Cry3A-like toxin with a 6×His tag"
 
 
<p> <figcaption><strong> Figure 3: </strong>pET30a-OmpA-Cry3A-like toxin with a 6×His tag </figcaption></p>
 
 
</figure>
 
 
<br>
 
<br>
 
 
 
 
<p><strong>2. Poisonous protein validation model</strong></p>
 
 
<p><strong>(1). Determination of ligand protein</strong></p>
 
 
We retrieved the amino acid sequence of the cadherin-like protein BT-R1 [ 2 ] from Manduca sexta in the NCBI database, which has been identified to interact with Bt Cry protein, and paired it with its homologous protein cadherin-23 in S.invicta using blast.
 
 
<p><strong>(2). Protein modeling and protein-protein docking</strong></p>
 
The homologous modeling of Cry3A-like protein and cadherin-23 was performed using swiss-model. The modeling results are as follows ( cadherin-23 left, Cry3A like protein right, <p>see Cry3A _ like _ protein.pdb, Cry3A _ like _ protein.stl, cadherin-23.pdb, cadherin-23.stl <a href="https://2023.igem.wiki/scau-china/model" class="pr-0" target="_blank">(scau-china/model)</a>).
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-3.png"
 
width="600"
 
 
</figure>
 
 
<br>
 
<br>
 
 
 
We used GRAMM ( Global RAnge Molecular Matching ) to dock our toxic proteins and ligand proteins. PDBePISA was used to analyze the docking results. The docking mutual surface size was 2465.8, and the binding free energy was-4.2. The binding free energy was less than 0, and the docking was meaningful.
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-5.png"
 
width="700"
 
 
</figure>
 
 
<br>
 
<br>
 
 
 
Among them, the hydrogen bonds and salt bridge sites formed by protein docking are shown in the following table.
 
 
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-6.png"
 
width="700"
 
 
</figure>
 
 
<br>
 
<br>
 
 
The docking surface is shown in the following figure ( see the docking.pdb, docking.x3d file [https://2023.igem.wiki/scau-china/model]).
 
 
 
<br>
 
 
 
<figure align="center">
 
<img
 
alt="parts1"
 
src="https://static.igem.wiki/teams/4632/wiki/wiki/registry-part/part-1-4.png"
 
width="700"
 
 
</figure>
 
  
 
<br>
 
<br>

Revision as of 15:30, 10 October 2023


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.




User Reviews

UNIQcca50f1c7326f1b3-partinfo-00000000-QINU UNIQcca50f1c7326f1b3-partinfo-00000001-QINU